Next-generation sequence analysis of genes associated with obesity and nonalcoholic fatty liver disease-related cirrhosis in extreme obesity

Human Heredity

Volumn 75, Issue 2-4, 2013, Pages 144-151

  Gerhard, Glenn S ^a,b   Chu, Xin ^a   Wood, G Craig ^a   Gerhard, Genevieve M ^a   Benotti, Peter ^c   Petrick, Anthony T ^a   Gabrielsen, Jon ^a   Strodel, William E ^a   Still, Christopher D ^a   Argyropoulos, George ^a  

^a GEISINGER MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c ST FRANCIS MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Extreme obesity; Genome wide association studies; Nonalcoholic fatty liver disease; Whole exome sequencing

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; LIVER CIRRHOSIS; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 GENE; GENE LOCUS; MISSENSE MUTATION; NEXT GENERATION SEQUENCING; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; EXOME; FATTY LIVER; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY, MORBID; SEQUENCE ANALYSIS, DNA;

EID: 84884990837     PISSN: 00015652     EISSN: 14230062     Source Type: Journal    
DOI: 10.1159/000351719     Document Type: Article

References (35)

1. Hebebrand J, Sommerlad C, Geller F, Gorg T, Hinney A: The genetics of obesity: practical implications. Int J Obes Relat Metab Disord 2001; 25(suppl 1):S10-S18.
2. Speakman JR: Obesity: the integrated roles of environment and genetics. J Nutr 2004; 134: 2090S-2105S.
3. Anstee QM, Daly AK, Day CP: Genetics of alcoholic and nonalcoholic fatty liver disease. Semin Liver Dis 2011; 31: 128-146.
4. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, et al: Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41: 25-34.
5. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894.
6. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, et al: Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40: 768-775.
7. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, et al: Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011; 7:e1001324.
8. Pearson TA, Manolio TA: How to interpret a genome-wide association study. JAMA 2008; 299: 1335-1344.
9. Ranadive SA, Vaisse C: Lessons from extreme human obesity: monogenic disorders. Endocrinol Metab Clin North Am 2008; 37: 733-751.
10. Ahituv N, Kavaslar N, Schackwitz W, Ustaszewska A, Martin J, Hebert S, Doelle H, Ersoy B, Kryukov G, Schmidt S, Yosef N, Ruppin E, Sharan R, Vaisse C, Sunyaev S, Dent R, Cohen J, McPherson R, Pennacchio LA: Medical sequencing at the extremes of human body mass. Am J Hum Genet 2007; 80: 779-791.
11. Mirshahi UL, Still CD, Masker KK, Gerhard GS, Carey DJ, Mirshahi T: The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery. J Clin Endocrinol Metab 2011; 96:E2088-E2096.
12. Harismendy O, Bansal V, Bhatia G, Nakano M, Scott M, Wang X, Dib C, Turlotte E, Sipe JC, Murray SS, Deleuze JF, Bafna V, Topol EJ, Frazer KA: Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level. Genome Biol 2010; 11:R118.
13. Gorlov IP, Gorlova OY, Frazier ML, Spitz MR, Amos CI: Evolutionary evidence of the effect of rare variants on disease etiology. Clin Genet 2011; 79: 199-206.
14. Cirulli ET, Goldstein DB: Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010; 11: 415-425.
15. Cotsapas C, Speliotes EK, Hatoum IJ, Greenawalt DM, Dobrin R, Lum PY, Suver C, Chudin E, Kemp D, Reitman M, Voight BF, Neale BM, Schadt EE, Hirschhorn JN, Kaplan LM, Daly MJ: Common body mass index-associated variants confer risk of extreme obesity. Hum Mol Genet 2009; 18: 3502-3507.
16. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA: An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65.
17. Chu X, Erdman R, Susek M, Gerst H, Derr K, Al-Agha M, Wood GC, Hartman C, Yeager S, Blosky MA, Krum W, Stewart WF, Carey D, Benotti P, Still CD, Gerhard GS: Association of morbid obesity with FTO and INSIG2 allelic variants. Arch Surg 2008; 143: 235-240; discussion 241.
18. Mencarelli M, Dubern B, Alili R, Maestrini S, Benajiba L, Tagliaferri M, Galan P, Rinaldi M, Simon C, Tounian P, Hercberg S, Liuzzi A, Di Blasio AM, Clement K: Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Hum Mol Genet 2011; 20: 392-399.
19. Butler AA, Cone RD: The melanocortin receptors: lessons from knockout models. Neuropeptides 2002; 36: 77-84.
20. Guo DF, Rahmouni K: Molecular basis of the obesity associated with Bardet-Biedl syndrome. Trends Endocrinol Metab 2011; 22: 286-293.
21. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249.
22. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP: Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012; 7:e46688.
23. Farooqi IS: Monogenic human obesity. Front Horm Res 2008; 36: 1-11.
24. Clark MJ, Chen R, Lam HY, Karczewski KJ, Euskirchen G, Butte AJ, Snyder M: Performance comparison of exome DNA sequencing technologies. Nat Biotechnol 2011; 29: 908-914.
25. Calton MA, Ersoy BA, Zhang S, Kane JP, Malloy MJ, Pullinger CR, Bromberg Y, Pennacchio LA, Dent R, McPherson R, Ahituv N, Vaisse C: Association of functionally significant melanocortin-4 but not melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Hum Mol Genet 2009; 18: 1140-1147.
26. Walters RG, Jacquemont S, Valsesia A, de Smith AJ, Martinet D, et al: A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010; 463: 671-675.
27. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, et al: An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
28. Hoch M, Eberle AN, Wagner U, Bussmann C, Peters T, Peterli R: Expression and localization of melanocortin-1 receptor in human adipose tissues of severely obese patients. Obesity (Silver Spring) 2007; 15: 40-49.
29. Gatti S, Colombo G, Turcatti F, Lonati C, Sordi A, Bonino F, Lipton JM, Catania A: Reduced expression of the melanocortin-1 receptor in human liver during brain death. Neuroimmunomodulation 2006; 13: 51-55.
30. Moore SJ, Green JS, Fan Y, Bhogal AK, Dicks E, Fernandez BA, Stefanelli M, Murphy C, Cramer BC, Dean JC, Beales PL, Katsanis N, Bassett AS, Davidson WS, Parfrey PS: Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study. Am J Med Genet A 2005; 132: 352-360.
31. Cox KF, Kerr NC, Kedrov M, Nishimura D, Jennings BJ, Stone EM, Sheffield VC, Iannaccone A: Phenotypic expression of Bardet- Biedl syndrome in patients homozygous for the common M390R mutation in the BBS1 gene. Vision Res 2012; 75: 77-87.
32. Shah AS, Farmen SL, Moninger TO, Businga TR, Andrews MP, Bugge K, Searby CC, Nishimura D, Brogden KA, Kline JN, Sheffield VC, Welsh MJ: Loss of Bardet-Biedl syndrome proteins alters the morphology and function of motile cilia in airway epithelia. Proc Natl Acad Sci USA 2008; 105: 3380-3385.
33. Zaghloul NA, Katsanis N: Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J Clin Invest 2009; 119: 428-437.
34. He S, McPhaul C, Li JZ, Garuti R, Kinch L, Grishin NV, Cohen JC, Hobbs HH: A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285: 6706-6715.
35. Sookoian S, Pirola CJ: Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011; 53: 1883-1894.